KCP researchers discover the surprising role of non-tumor cells in kidney cancer's resistance to rapalog drugs, such as rapamycin. This discovery could lead to new strategies targeting TME cells to overcome drug resistance in kidney cancer. Read more here: bit.ly/rapalog_resist…

Virtual registration for KidneyCAN's Kidney Cancer Research Summit is FREE for academic, research, advocacy, industry, and patient/caregiver attendees! The event will be live-streamed via Zoom from Boston on July 11th-12th. Don't miss out on this chance...Sign up today!

🎉We're thrilled to congratulate Dr. Qing Zhang on winning the Chinese Biological Investigators Society (CBIS) Young Investigator Award this year! This award highlights Qing Zhang's outstanding contributions to the field, with many more to come. #YoungInvestiagtors #utsw

Eight distinguished awardees will be supported as part of Kidney Cancer SPORE Year 8 Developmental Research & Career Enhancement Programs (DRP & CRP). Congratulations, this is well deserved!👏 ##utsw #kidneycancer

Register for Kidney Cancer's upcoming Virtual Patient Symposium on September 21! Experts including our own Dr. Raquibul Hannan will be speaking about kidney cancer related treatment decisions. Sign up here: kidneycancer.org/patient-educat… #kidneycancer

Congrats to @RJDLab for their remarkable paper published in nature. Their work highlights the complex role of mitochondrial function in metastasis and opens new avenues for targeted therapies. Kudos to the team for advancing our understanding of cancer metabolism!

Pleased to recognize these CPRIT grants to UTSW Simmons Cancer Center members that should enhance our peer-reviewed funding #s in the upcoming competing renewal of our NCI core grant & comprehensive designation. Great for the our mission in North Texas & beyond! cprit.texas.gov/news-events/ar…

Congratulations on your new role, Dr. DeBerardinis!

We’re thrilled to announce that several UTSW researchers have been awarded CPRIT grants for their work in kidney cancer research! Stay tuned as we spotlight some of these awardees and their projects over the next few days. kcp.utsw.edu/utsw-newsroom/…

Today we highlight Dr. Kevin Courtney, who received the Clinical Investigator Award. This award will support his clinical research in genitourinary oncology, mentoring of junior faculty, and studies on kidney cancer metabolism. Congrats!

Dr. Ralph DeBerardinis received the Core Facility Award, enabling his team to expand tools for assessing metabolism in kidney cancer and other tumors, with the goal of identifying and targeting metabolic weaknesses to improve cancer treatment. Congrats, @RJDLab!

Celebrating success! 🎉 Our Kidney Cancer SPORE Year 8 DRP & CEP awardees and colleagues came together for a fun pizza gathering to mark their incredible achievements. 🍕 We're proud to support these talented individuals who are making strides in kidney cancer research!

Learn how kidney cancer fuels its spread in this Science in 60+ video featuring Dr. DeBerardinis. UTSW researchers found that while primary kidney tumors behave one way, metastatic ones rely on mitochondria for energy. #kidneycancer #utsw #research tinyurl.com/3swc87rm

Exciting news! 🎉 Three #UTSW researchers received the DoD #KCRP Postdoctoral & Clinical Fellowship Awards! Dr. Jun Fang (Qing Zhang), Dr. Arijit Mal (James Brugarolas Lab), & Dr. Dylan Wang (Qing Zhang) 👏Congrats to all! Read more: kcp.utsw.edu/utsw-newsroom/… #kidneycancer

March 30th was #NationalDoctorsDay! We echo Dr. Podolsky: ‘Your ability to listen, empathize, and guide patients with expertise through... difficult and joyful moments epitomizes our values and mission.’ We are grateful for our physicians' compassion, dedication, & impact! #UTSW

🧬Dr. Brugarolas recently spoke with GU Oncology Now, reflecting on the path to FDA-approved HIF-2 inhibitors and the future of personalized therapy, immunotherapy, and genetic medicine in kidney cancer. #UTSW #kidneycancer #research guoncologynow.com/post/from-vegf…

Drs. Rajaram and Payal Kapur of the Kidney Cancer Program, co-led a groundbreaking Nature Communications study using AI to predict which patients with clear-cell kidney cancer will benefit from anti-angiogenic therapy. A major step toward more accessible precision medicine!👏

A study co-led by Ben Sabari found that a gene fusion drives rare kidney cancer (tRCC) by forming protein clusters that disrupt gene activity. This may also occur in other cancers, revealing a potential new target for future therapies. #KidneyCancer #utsw bit.ly/3TSNOlW

How do cancer cells escape death? Dr. Garcia-Bermudez (Javier Garcia-Bermudez) and his team found they hijack fat molecules to shield themselves. Featured in Dallas Morning News + nature, this discovery could open new doors for cancer therapy. #utsw #kidneycancer

UTSW is ranked #1 globally among health care institutions in biological sciences, according to the latest Nature Index (Mar 2024–Feb 2025). The ranking reflects the strength of our research community and contributions to journals tracked by Nature Index. bit.ly/45l31mp